Net Income (Loss) Attributable to Parent in USD of Tonix Pharmaceuticals Holding Corp. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • Tonix Pharmaceuticals Holding Corp. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$32,010,000.000, a 125% decline year-over-year.
  • Tonix Pharmaceuticals Holding Corp. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$99,219,000.000, a 26.6% increase year-over-year.
  • Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2024 was -$130,036,000.000, a 11.5% decline from 2023.
  • Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$116,658,000.000, a 5.84% decline from 2022.
  • Tonix Pharmaceuticals Holding Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$110,218,000.000, a 19.4% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Tonix Pharmaceuticals Holding Corp. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$99,219,000 -$32,010,000 -$17,797,000 -1.3% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$81,422,000 -$28,272,000 +$50,504,000 +64.1% 01 Apr 2025 30 Jun 2025 10-Q 10 Nov 2025
Q1 2025 -$131,926,000 -$16,829,000 -$1,890,000 -12.7% 01 Jan 2025 31 Mar 2025 10-Q 10 Nov 2025
Q4 2024 -$130,036,000 -$22,108,000 +$5,214,000 +19.1% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025
Q3 2024 -$135,250,000 -$14,213,000 +$13,762,000 +49.2% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$149,012,000 -$78,776,000 -$50,420,000 -1.8% 01 Apr 2024 30 Jun 2024 10-Q 10 Nov 2025
Q1 2024 -$98,592,000 -$14,939,000 +$18,066,000 +54.7% 01 Jan 2024 31 Mar 2024 10-Q 10 Nov 2025
Q4 2023 -$116,658,000 -$27,322,000 +$4,358,000 +13.8% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 -$121,016,000 -$27,975,000 +$1,006,000 +3.5% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$122,022,000 -$28,356,000 -$5,216,000 -22.5% 01 Apr 2023 30 Jun 2023 10-Q 12 Nov 2024
Q1 2023 -$116,806,000 -$33,005,000 -$6,588,000 -24.9% 01 Jan 2023 31 Mar 2023 10-Q 12 Nov 2024
Q4 2022 -$110,218,000 -$31,680,000 -$2,127,000 -7.2% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 -$108,091,000 -$28,981,000 -$10,453,000 -56.4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$97,638,000 -$23,140,000 +$413,000 +1.8% 01 Apr 2022 30 Jun 2022 10-Q 09 Nov 2023
Q1 2022 -$98,051,000 -$26,417,000 -$5,764,000 -27.9% 01 Jan 2022 31 Mar 2022 10-Q 09 Nov 2023
Q4 2021 -$92,287,000 -$29,553,000 -$12,532,000 -73.6% 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2023
Q3 2021 -$79,755,000 -$18,528,000 -$6,538,000 -54.5% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$73,217,000 -$23,553,000 -$9,374,000 -66.1% 01 Apr 2021 30 Jun 2021 10-Q 07 Nov 2022
Q1 2021 -$63,843,000 -$20,653,000 -$13,380,000 -1.8% 01 Jan 2021 31 Mar 2021 10-Q 07 Nov 2022
Q4 2020 -$50,463,000 -$17,021,000 -$8,314,000 -95.5% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 -$42,149,000 -$11,990,000 -$4,152,000 -53% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$37,997,000 -$14,179,000 -$8,339,000 -1.4% 01 Apr 2020 30 Jun 2020 10-Q 08 Nov 2021
Q1 2020 -$29,658,000 -$7,273,000 -$1,040,000 -16.7% 01 Jan 2020 31 Mar 2020 10-Q 08 Nov 2021
Q4 2019 -$28,618,000 -$8,707,000 -$1,119,000 -14.7% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 -$27,499,000 -$7,838,000 -$2,359,000 -43.1% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$25,140,000 -$5,840,000 +$247,000 +4.1% 01 Apr 2019 30 Jun 2019 10-Q 09 Nov 2020
Q1 2019 -$25,387,000 -$6,233,000 +$702,000 +10.1% 01 Jan 2019 31 Mar 2019 10-Q 09 Nov 2020
Q4 2018 -$26,089,000 -$7,588,000 -$2,095,000 -38.1% 01 Oct 2018 31 Dec 2018 10-K 24 Mar 2020
Q3 2018 -$23,994,000 -$5,479,000 +$307,000 +5.3% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 -$24,301,000 -$6,087,000 -$1,307,000 -27.3% 01 Apr 2018 30 Jun 2018 10-Q 08 Nov 2019
Q1 2018 -$22,994,000 -$6,935,000 -$1,871,000 -36.9% 01 Jan 2018 31 Mar 2018 10-Q 08 Nov 2019
Q4 2017 -$21,123,000 -$5,493,000 +$1,989,000 +26.6% 01 Oct 2017 31 Dec 2017 10-K 18 Mar 2019
Q3 2017 -$23,112,000 -$5,786,000 +$1,792,000 +23.6% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 -$24,904,000 -$4,780,000 +$5,026,000 +51.3% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 -$29,930,000 -$5,064,000 +$8,912,000 +63.8% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 -$38,842,000 -$7,482,000 +$5,878,000 +44% 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 -$44,720,000 -$7,578,000 +$5,672,000 +42.8% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017
Q2 2016 -$50,392,000 -$9,806,000 +$1,957,000 +16.6% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$52,349,000 -$13,976,000 -$4,295,000 -44.4% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$48,054,000 -$13,360,000 -$4,371,000 -48.6% 01 Oct 2015 31 Dec 2015 10-K 03 Mar 2016
Q3 2015 -$43,683,000 -$13,250,000 -$5,831,000 -78.6% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 -$37,852,000 -$11,763,000 -$5,719,000 -94.6% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 -$32,133,000 -$9,681,000 -$4,517,000 -87.5% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016
Q4 2014 -$27,616,000 -$8,989,000 -$5,282,000 -1.4% 01 Oct 2014 31 Dec 2014 10-K 03 Mar 2016
Q3 2014 -$22,334,000 -$7,419,000 -$4,329,000 -1.4% 01 Jul 2014 30 Sep 2014 10-K 03 Mar 2016
Q2 2014 -$18,005,000 -$6,044,000 -$3,958,000 -1.9% 01 Apr 2014 30 Jun 2014 10-K 03 Mar 2016
Q1 2014 -$14,047,000 -$5,164,000 -$3,163,000 -1.6% 01 Jan 2014 31 Mar 2014 10-K 03 Mar 2016
Q4 2013 -$10,884,000 -$3,707,000 +$263,958 +6.6% 01 Oct 2013 31 Dec 2013 10-K 03 Mar 2016
Q3 2013 -$11,147,958 -$3,090,000 -$1,357,973 -78.4% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 -$9,789,985 -$2,086,000 -$353,973 -20.4% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 -$9,436,012 -$2,001,000 +$13,988 +0.69% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014
Q4 2012 -$9,450,000 -$3,970,958 -$2,384,902 -1.5% 01 Oct 2012 31 Dec 2012 10-K 28 Mar 2014
Q3 2012 -$7,065,098 -$1,732,027 -$717,549 -70.7% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2012
Q2 2012 -$6,347,549 -$1,732,027 -$1,376,217 -3.9% 01 Apr 2012 30 Jun 2012 10-Q 13 Nov 2013
Q1 2012 -$4,971,332 -$2,014,988 -$1,501,332 -2.9% 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013
Q4 2011 -$3,470,000 -$1,586,056 01 Oct 2011 31 Dec 2011 10-K 28 Mar 2014
Q3 2011 -$1,014,478 -$1,010,793 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 -$355,810 -$353,408 01 Apr 2011 30 Jun 2011 10-Q 13 Aug 2012
Q1 2011 -$513,656 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$3,685* 01 Jul 2010 30 Sep 2010 10-Q 07 Oct 2011
Q2 2010 -$2,402* 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

Tonix Pharmaceuticals Holding Corp. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$130,036,000 -$13,378,000 -11.5% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025
2023 -$116,658,000 -$6,440,000 -5.8% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025
2022 -$110,218,000 -$17,931,000 -19.4% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$92,287,000 -$41,824,000 -82.9% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2023
2020 -$50,463,000 -$21,845,000 -76.3% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022
2019 -$28,618,000 -$2,529,000 -9.7% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 -$26,089,000 -$4,966,000 -23.5% 01 Jan 2018 31 Dec 2018 10-K 24 Mar 2020
2017 -$21,123,000 +$17,719,000 +45.6% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019
2016 -$38,842,000 +$9,212,000 +19.2% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018
2015 -$48,054,000 -$20,438,000 -74% 01 Jan 2015 31 Dec 2015 10-K 13 Apr 2017
2014 -$27,616,000 -$16,732,000 -1.5% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2016
2013 -$10,884,000 -$1,434,000 -15.2% 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016
2012 -$9,450,000 -$5,980,000 -1.7% 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2014
2011 -$3,470,000 -$1,506,000 -76.7% 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2014
2010 -$1,964,000 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.